233
Participants
Start Date
January 22, 2019
Primary Completion Date
December 10, 2019
Study Completion Date
January 21, 2020
5 mg Serlopitant Tablets
Serlopitant Tablets
Matching Placebo Tablets
Placebo Tablets
Study Site 802, The Bronx
Study Site 507, Brooklyn
Study Site 522, Pittsburgh
Study Site 217, Norfolk
Study Site 341, High Point
Study Site 810, Raleigh
Study Site 349, Savannah
Study Site 801, Jacksonville
Study Site 807, Miami
Study Site 331, Miami
Study Site 811, Aventura
Study Site 818, West Palm Beach
Study Site 824, Sarasota
Study Site 805, Nashville
Study Site 524, Dublin
Study Site 814, Indianapolis
Study Site 817, St Louis
Study Site 371, Saint Joseph
Study Site 822, Rolla
Study Site 821, Bellevue
Study Site 221, Hot Springs
Study Site 120, Dallas
Study Site 819, Fort Worth
Study Site 809, San Antonio
Study Site 359, Pflugerville
Study Site 365, Austin
Study Site 820, Centennial
Study Site 804, Denver
Study Site 813, Las Vegas
Study Site 387, Las Vegas
Study Site 803, Los Angeles
Study Site 823, Bakersfield
Study Site 204, Fremont
Study Site 116, Portland
Study Site 806, Spokane
Study Site 808, Brighton
Study Site 816, Morristown
Study Site 121, Ocean Township
Study Site 345, Johnston
Study Site 815, Warwick
Study Site 812, Walla Walla
Vyne Therapeutics Inc.
INDUSTRY